Smart mask aims to measure blood oxygen through your face

NCT ID NCT07086742

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers are testing a new face mask, the Smart Mask V1 System, that uses built-in light sensors to measure blood oxygen (SpO2) and pulse rate. The study enrolls healthy adults aged 18 to 65 who wear the mask while breathing air with gradually lower oxygen levels in a special room. The goal is to see if the mask's readings match those from standard fingertip oximeters and blood tests, and whether skin pigmentation affects accuracy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Smart Mask V1 System, a face mask with built-in light sensors that measure blood oxygen and pulse rate
What this could lead to
If it works, the Smart Mask could offer a comfortable way to monitor breathing and oxygen levels during sleep, possibly helping detect sleep apnea or other breathing problems.
What could go wrong
This is an early validation study in healthy adults, so the mask may not measure as accurately as standard devices, especially across different skin tones. The study does not test whether the mask improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

53 people

The number who actually took part.

Started

Jul 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy subjects with ASA health score of I or II * Subjects aged between ≥ 18 and ≤ 65 years. * Subjects who have provided informed consent and are willing to comply with the study procedures. Exclusion Criteria: * Heavy smokers or individuals exposed to high levels of carbon monoxide resulting in elevated carboxyhemoglobin levels. * Individuals with conditions that result in elevated methemoglobin levels. * Individuals with hypoxia (SpO2 \< 95% at 21% O2). * Severe claustrophobia. * Subjects known with altitude sickness. * Subjects who are obese (BMI ≥ 35 kg/m2). * Subjects with a known history of moderate to severe heart, lung, kidney or liver disease. * Subjects diagnosed with moderate to severe asthma. * Subjects with a hemoglobinopathy or history of anemia, e.g. sickle cell anemia, thalassemia, that in the investigator's opinion, would make them unsuitable for study participation. * Subjects with any other serious systemic illness. * Any injury, deformity, or abnormality at the sensor sites that, in the investigator's opinion, would interfere with the correct functioning of the test or reference devices. * Subjects with a history of fainting or vasovagal response. * Subjects with a history of sensitivity or allergy to local anesthetics or disinfectants if included in the IN study. * Subjects diagnosed with Raynaud's disease. * Subjects with unacceptable collateral circulation based on examination by the investigator. * Subjects who are pregnant, lactating or trying to become pregnant. * Subjects unable or unwilling to provide informed consent or comply with study procedures. * Subjects with any other condition that, in the investigator's opinion, would make them unsuitable for the study. * Subjects who refuse to remove nail polish from their index finger. * Volunteers not willing to remove facial make-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep apnea are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Complementair Medisch Centrum (CMC) Europe

    Genk, 3600, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.